Top Markets
#1 SSV Network SSV Network +22.92%
#2 EXOD EXOD +22.08%
#3 Derive Derive +21.36%
#4 Velvet Velvet +21.35%
#5 The Black Bull The Black Bull +21.24%
#6 XPIN Network XPIN Network +18.75%
#7 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.45%
#8 wojak wojak +18.32%
#9 Bitcoin Cash Bitcoin Cash +18.11%
#10 Arowana Arowana +17.65%
Coin of the day
SSV Network SSV Network
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Kidswell Bio Corporation Kidswell Bio Corporation

Kidswell Bio Corporation

4584
Kedudukan dalam Saham #24929
Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the... Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the development of pharmaceutical treatments for rare and complex diseases. The company, which was founded in 2001 and operated as Gene Techno Science Co.,Ltd. until rebranding in July 2021, maintains a robust pipeline of therapeutic candidates. This includes GND-004, designed for both ophthalmic conditions and oncology, and GND-007, aimed at immunological disorders. Their portfolio also features a range of antibodies being developed for cancer therapies. Further expanding its research, the GBS series encompasses GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for eye-related ailments; GBS-008 for infectious diseases; and GBS-011 for renal conditions. Additionally, Kidswell Bio is progressing GCT-101 for alveolar clefts, GCT-102 for congenital isolated hypoganglionosis, alongside other investigational products addressing ophthalmologic disorders, cerebral palsy, peripheral nerve palsy, fractures, and spinal cord injuries.
Harga Saham
$1.11
Modal Pasaran
$55.05M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-36.23%
Negara
JP
Perdagangan Kidswell Bio Corporation (4584)

Kategori

Healthcare
Nisbah P/E bagi Kidswell Bio Corporation (4584)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Kidswell Bio Corporation, nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Kidswell Bio Corporation dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.